A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
Aisha Al-DherasiQi-Tian HuangYuwei LiaoSultan Al-MosaibRulin HuaYichen WangYing YuYu ZhangXuehong ZhangChao HuangHaithm MousaDongcen GeSufiyan SufiyanWanting BaiRuimei LiuYanyan ShaoYulong LiJingkai ZhangLeming ShiDekang LvZhiguang LiQuentin LiuPublished in: Cancer cell international (2021)
Our study suggested a new and reliable prognostic signature that has a significant implication in predicting overall survival for LUAD patients and may help with early diagnosis and making effective clinical decisions regarding potential individual treatment.